HomeMNMD • NASDAQ
add
Mind Medicine (MindMed) Inc
Previous close
$6.55
Day range
$6.51 - $6.74
Year range
$4.70 - $10.44
Market cap
498.65M USD
Avg Volume
1.04M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 32.16M | 44.83% |
Net income | -23.35M | 57.08% |
Net profit margin | — | — |
Earnings per share | -0.35 | 69.30% |
EBITDA | -32.15M | -48.32% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 212.44M | -15.81% |
Total assets | 275.32M | -0.08% |
Total liabilities | 52.52M | -33.92% |
Total equity | 222.81M | — |
Shares outstanding | 75.55M | — |
Price to book | 2.22 | — |
Return on assets | -27.84% | — |
Return on capital | -31.64% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -23.35M | 57.08% |
Cash from operations | -29.42M | -77.24% |
Cash from investing | -162.46M | — |
Cash from financing | 1.00M | -99.41% |
Net change in cash | -190.89M | -225.07% |
Free cash flow | -26.82M | -207.69% |
About
Mind Medicine Inc., doing business as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
Founded
2010
Website
Employees
74
